Investing News

Genetics Investing

NewLink Genetics Receives FDA Acceptance for Partnered Biologics License Application

Markets
TSX	21149.00	+23.10
TSXV	954.26	+10.21
DOW	35135.94	+236.60
S&P 500	4655.27	+60.65
NASD	15782.83	+291.18
ASX	7279.30	-128.00

Markets

TSX

21149.00

+23.10

TSXV

954.26

+10.21

DOW

35135.94

+236.60

S&P 500

4655.27

+60.65

NASD

15782.83

+291.18

ASX

7279.30

-128.00

Commodities
Gold	1786.91	+0.28
Silver	22.89	-0.03
Copper	4.36	+0.01
Palladium	1801.50	+12.58
Platinum	963.00	-3.00
Oil	70.90	+0.95
Heating Oil	2.17	+0.02
Natural Gas	4.86	0.00

Commodities

Gold

1786.91

+0.28

Silver

22.89

-0.03

Copper

4.36

+0.01

Palladium

1801.50

+12.58

Platinum

963.00

-3.00

Oil

70.90

+0.95

Heating Oil

2.17

+0.02

Natural Gas

4.86

0.00

Investing News NetworkYour trusted source for investing success

genetics investing

5 Top Genetic Testing Stocks

Top NASDAQ Genetics Stocks

10 Top Stem Cell Companies on the NASDAQ

Anti-aging Stocks in the US

Top NASDAQ Genetics Stocks

5 Largest Genetics Stocks by Market Cap

5 Gene Therapy Stocks for Investors

How to Invest in Genetics

Cancer Genetics Reports Q3 Financial Results

Sangamo to Present Gene Therapy and Ex Vivo Gene-Edited Cell Therapy Data

ProQR Announces Positive Phase 1/2 Study of Sepofarsen

Top NASDAQ Genetics Stocks

The Rise of CRISPR Technology

5 Top Genetics News Stories of 2019

CRISPR and Vertex Release Positive Gene-editing Results

Sarepta Therapeutics Strikes Partnership with StrideBio

Applied Genetic Technologies Announces Strategic Collaboration with Otonomy

CareDx Files Lawsuit Against Eurofins Viracor

NewLink Genetics Receives FDA Acceptance for Partnered Biologics License Application

Wave Life Sciences Gets Fast Track Designation from FDA

Fulgent Genetics Launches Picture Genetics

Mesoblast and Grunenthal Partner on Lower Back Pain Cell Therapy

Rocket Pharmaceuticals Announces Data from Phase 1/2 Trial of RP-L102

MARKETS

COMMODITIES